BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25652053)

  • 1. Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients.
    Chok AY; Goh BK; Koh YX; Lye WK; Allen JC; Quek R; Teo MC; Chow PK; Ong HS; Chung AY; Wong WK
    Ann Surg Oncol; 2015 Oct; 22(11):3597-605. PubMed ID: 25652053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
    Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
    Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study.
    Chen T; Ye LY; Feng XY; Qiu HB; Zhang P; Luo YX; Yuan LY; Chen XH; Hu YF; Liu H; Li Y; Tao KX; Yu J; Li GX
    World J Gastroenterol; 2019 Mar; 25(10):1238-1247. PubMed ID: 30886506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.
    Gold JS; Gönen M; Gutiérrez A; Broto JM; García-del-Muro X; Smyrk TC; Maki RG; Singer S; Brennan MF; Antonescu CR; Donohue JH; DeMatteo RP
    Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
    Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
    Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developed and validated a prognostic nomogram for recurrence-free survival after complete surgical resection of local primary gastrointestinal stromal tumors based on deep learning.
    Chen T; Liu S; Li Y; Feng X; Xiong W; Zhao X; Yang Y; Zhang C; Hu Y; Chen H; Lin T; Zhao M; Liu H; Yu J; Xu Y; Zhang Y; Li G
    EBioMedicine; 2019 Jan; 39():272-279. PubMed ID: 30587460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
    Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
    Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis.
    Tanimine N; Tanabe K; Suzuki T; Tokumoto N; Ohdan H
    World J Surg Oncol; 2012 Feb; 10():43. PubMed ID: 22348408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of current prognostication systems for primary gastrointestinal stromal tumors.
    Khoo CY; Chai X; Quek R; Teo MCC; Goh BKP
    Eur J Surg Oncol; 2018 Apr; 44(4):388-394. PubMed ID: 29422251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.
    Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W
    Front Oncol; 2020; 10():581855. PubMed ID: 33585198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World.
    Nishida T; Cho H; Hirota S; Masuzawa T; Chiguchi G; Tsujinaka T;
    Ann Surg Oncol; 2018 Jul; 25(7):1961-1969. PubMed ID: 29752602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
    Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
    Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict disease-free survival after surgical resection of GIST.
    Bischof DA; Kim Y; Behman R; Karanicolas PJ; Quereshy FA; Blazer DG; Maithel SK; Gamblin TC; Bauer TW; Pawlik TM
    J Gastrointest Surg; 2014 Dec; 18(12):2123-9. PubMed ID: 25245766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
    Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
    JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
    Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
    Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
    Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
    Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and external validation of a nomogram for individualized adjuvant imatinib duration for high-risk gastrointestinal stromal tumors: A multicenter retrospective cohort study.
    Liu R; Wu Y; Gong J; Zhao R; Li L; Wan Q; Lian N; Shen X; Xia L; Shen Y; Xiao H; Wu X; Chen Y; Cen Y; Xu X
    Cancer Med; 2022 Aug; 11(16):3093-3105. PubMed ID: 35297216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary role of the Memorial Sloan Kettering Cancer Center nomogram to the American Joint Committee on Cancer system for the prediction of relapse of major salivary gland carcinoma after surgery.
    Chou WC; Chang KP; Lu CH; Chen MF; Cheng YF; Yeh KY; Wang CH; Lin YC; Yeh TS
    Head Neck; 2017 May; 39(5):860-867. PubMed ID: 28152230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor.
    Ran P; Tan T; Zhou H; Li J; Yang H; Li J; Zhang J
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population.
    Chen D; Jiang B; Xing J; Liu M; Cui M; Liu Y; Wang Z; Chen L; Yang H; Zhang C; Yao Z; Zhang N; Ji J; Qu H; Su X
    PLoS One; 2013; 8(10):e76041. PubMed ID: 24146811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.